AstraZeneca, Medical Research Council (MRC), MRC Mammalian Genetics Unit Harwell, Imperial College London, Royal Veterinary College, University of Birmingham, U

The MRC awarded £7 million ($11.3 million) in funding for 15 research projects to the universities and institutes to evaluate compounds provided by AstraZeneca. MRC said the disease areas include Alzheimer's disease, cancer, lung disease, motor neuron disease and muscular dystrophies. Eight of the projects will involve clinical trials with the compounds, while seven projects will focus on preclinical work. MRC could not be reached for additional details on the projects. ...